3069291-10-4
3069291-10-4
Chemical Structure
CG-0988
- CAS No.: 3069291-10-4
- Formula:C29H28FN5O4
- Molecular Weight:529.56
InChIKey: VIARCOMDGNQPBM-RIRMVKJXSA-N
SMILES: O=C(C1CC1)C2=CC3=C(N2)C(N([C@@H](CC(F)(C)C)C(N4C[C@]5(C[C@H]4C#N)C(NC6=C5C=CC=C6)=O)=O)C=C3)=O
Biological Activity: CG-0988 is a selective SARS-CoV-2 3C-like protease (3CLpro) inhibitor with an IC50 of 8.5 nM. CG-0988 functionally inhibits SARS-CoV-2 3CLpro, blocks SARS-CoV-2 replication, and exerts antiviral activity against SARS-CoV-2 variants. CG-0988 can be used in research related to coronavirus disease 2019 (COVID-19)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CG-0988 | CG-0988 is a selective SARS-CoV-2 3C-like protease (3CLpro) inhibitor with an IC50 of 8.5 nM. CG-0988 functionally inhibits SARS-CoV-2 3CLpro, blocks SARS-CoV-2 replication, and exerts antiviral activity against SARS-CoV-2 variants. CG-0988 can be used in research related to coronavirus disease 2019 (COVID-19). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
